Kiromic Biopharma, Inc. Increase (Decrease) in Unbilled Receivables
Kiromic Biopharma, Inc. reported Increase (Decrease) in Unbilled Receivables of -$24.30 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-31.
Discontinued › Notes
us-gaap:IncreaseDecreaseInUnbilledReceivables · last filed 2021-03-31
- Kiromic Biopharma, Inc. increase (decrease) in unbilled receivables for the quarter ending 2019-12-31 was -$19.30K.
- Kiromic Biopharma, Inc. increase (decrease) in unbilled receivables for fiscal 2019 was -$24.30K.
| Period end | Increase (Decrease) in Unbilled Receivables 3 month | Increase (Decrease) in Unbilled Receivables 9 month | Increase (Decrease) in Unbilled Receivables 12 month |
|---|---|---|---|
| 2019-12-31 | -$19.30K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | -$24.30K 10-K · filed 2021-03-31 | |
| 2019-09-30 | -$5.00K 10-Q · filed 2020-11-30 |